Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07466212) titled 'QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy' on March 6.

Study Type: Observational [Patient Registry]

Primary Sponsor: Odense University Hospital

Condition: Cancer Type 2 Diabetes

Recruitment Status: Not recruiting

Date of First Enrollment: March 10, 2026

Target Sample Size: 920

Countries of Recruitment: Denmark

To know more, visit https://clinicaltrials.gov/study/NCT07466212

Published by HT Digital Content Services with permission from Health Daily Digest....